The Immunopathology of Multiple Sclerosis: An Overview
暂无分享,去创建一个
[1] J. Charcot. Leçons sur les Maladies Du Système Nerveux Faites à La Salpêtrière , 2009 .
[2] D. Chari,et al. Remyelination In Multiple Sclerosis , 2007, International Review of Neurobiology.
[3] Hans Lassmann,et al. Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis , 2007, Brain pathology.
[4] Hans Lassmann,et al. Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.
[5] B. Engelhardt,et al. Dysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis , 2006, Journal of neuropathology and experimental neurology.
[6] Hans Lassmann,et al. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.
[7] W. Brück,et al. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. , 2006, Brain : a journal of neurology.
[8] B. Cree. Emerging Monoclonal Antibody Therapies for Multiple Sclerosis , 2006, The neurologist.
[9] B. Weinshenker,et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. , 2006, Archives of neurology.
[10] Hans Lassmann,et al. Cortical demyelination in multiple sclerosis: A substrate for cognitive deficits? , 2006, Journal of the Neurological Sciences.
[11] M. Krumbholz,et al. B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation , 2006, Annals of neurology.
[12] B. Weinshenker,et al. Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.
[13] E. Frohman,et al. Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.
[14] S. Vukusic,et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis , 2006, Annals of neurology.
[15] F. Aloisi,et al. Lymphoid neogenesis in chronic inflammatory diseases , 2006, Nature Reviews Immunology.
[16] R. Rudick,et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients , 2006, Annals of neurology.
[17] P. Matthews,et al. Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. , 2005, Brain : a journal of neurology.
[18] Hans Lassmann,et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.
[19] A. Verkman,et al. The Journal of Experimental Medicine CORRESPONDENCE , 2005 .
[20] B. Weinshenker,et al. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange , 2005, The Lancet.
[21] L. Fugger,et al. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? , 2005, Brain : a journal of neurology.
[22] Peter K. Stys,et al. General mechanisms of axonal damage and its prevention , 2005, Journal of the Neurological Sciences.
[23] Kenneth J. Smith,et al. Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide , 2005, Brain : a journal of neurology.
[24] S. Ludwin,et al. Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis. , 2005, Brain : a journal of neurology.
[25] L. Bö,et al. The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions , 2005, Journal of neuropathology and experimental neurology.
[26] M. Esiri,et al. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. , 2004, Brain : a journal of neurology.
[27] J. Hallervorden. Die zentralen Entmarkungskrankheiten , 1940, Deutsche Zeitschrift für Nervenheilkunde.
[28] H. Waldmann,et al. The window of therapeutic opportunity in multiple sclerosis , 2005, Journal of Neurology.
[29] Ichiro Nakashima,et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.
[30] R. Hohlfeld,et al. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. Lucchinetti,et al. Evidence for pathogenic heterogeneity in multiple sclerosis , 2004, Annals of neurology.
[32] B. Serafini,et al. Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.
[33] M. Barnett,et al. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.
[34] S. McQuaid,et al. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood–brain barrier leakage and active demyelination , 2003, The Journal of pathology.
[35] R. Reynolds,et al. Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult , 2003, Brain pathology.
[36] B D Trapp,et al. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration , 2003, Multiple sclerosis.
[37] Frederik Barkhof,et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. , 2003, Archives of neurology.
[38] B. Trapp,et al. Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.
[39] L. Steinman,et al. Diverse Targets for Intervention during Inflammatory and Neurodegenerative Phases of Multiple Sclerosis , 2003, Neuron.
[40] P. Adeleine,et al. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. , 2003, Brain : a journal of neurology.
[41] K. Jellinger,et al. Preferential Loss of Myelin‐Associated Glycoprotein Reflects Hypoxia‐Like White Matter Damage in Stroke and Inflammatory Brain Diseases , 2003, Journal of neuropathology and experimental neurology.
[42] H. Grossniklaus. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Luchinetti CF,∗ Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuck D, Parisi JE, Lassman H. Brain 2002;125:1450–1461 , 2002 .
[43] R. Reynolds,et al. Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? , 2002, Brain : a journal of neurology.
[44] David H. Miller,et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.
[45] Hans Lassmann,et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. , 2002, Brain : a journal of neurology.
[46] H. Neumann,et al. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases , 2002, Trends in Neurosciences.
[47] H. Lassmann,et al. CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation , 2002, Nature Medicine.
[48] C. Elger,et al. Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in rasmussen's encephalitis , 2002, Annals of neurology.
[49] M. Filippi,et al. Primary Progressive Multiple Sclerosis , 2002, Topics in Neuroscience.
[50] E. Cho,et al. Immunopathology of secondary‐progressive multiple sclerosis , 2001, Annals of neurology.
[51] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[52] P M Matthews,et al. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. , 2001, Brain : a journal of neurology.
[53] H. Wekerle,et al. Myelin Antigen-Specific CD8+ T Cells Are Encephalitogenic and Produce Severe Disease in C57BL/6 Mice1 , 2001, The Journal of Immunology.
[54] H. Lassmann,et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. , 2001, Immunity.
[55] I. V. Allen,et al. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis , 2001, Neurological Sciences.
[56] C Confavreux,et al. Relapses and progression of disability in multiple sclerosis. , 2000, The New England journal of medicine.
[57] S. Majumder,et al. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation , 2000, Immunological reviews.
[58] P. Matthews,et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. , 2000, Brain : a journal of neurology.
[59] Hans Lassmann,et al. Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction , 2000, The Journal of experimental medicine.
[60] H. Lassmann,et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. , 2000, The American journal of pathology.
[61] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[62] T. Tabira. [Concentric sclerosis (Baló)]. , 2000, Ryoikibetsu shokogun shirizu.
[63] B. Scheithauer,et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.
[64] W. Brück,et al. Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination , 1999, Multiple sclerosis.
[65] F. Barkhof,et al. Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.
[66] H. Lassmann,et al. Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination , 1998, Annals of neurology.
[67] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[68] M. Esiri,et al. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. , 1997, Brain : a journal of neurology.
[69] J M Land,et al. Nitric Oxide‐Mediated Mitochondrial Damage in the Brain: Mechanisms and Implications for Neurodegenerative Diseases , 1997, Journal of neurochemistry.
[70] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[71] C. Raine,et al. The adhesion molecule and cytokine profile of multiple sclerosis lesions , 1995, Annals of neurology.
[72] K. Jellinger,et al. Patterns of oligodendroglia pathology in multiple sclerosis. , 1994, Brain : a journal of neurology.
[73] J. Prineas,et al. Blood‐Brain Barrier Abnormalities in Longstanding Multiple Sclerosis Lesions. An Immunohistochemical Study , 1994, Journal of neuropathology and experimental neurology.
[74] E. Cho,et al. Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions , 1993 .
[75] E. Cho,et al. Multiple sclerosis: remyelination of nascent lesions. , 1993, Annals of neurology.
[76] A. Thompson,et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.
[77] J. Benjamins,et al. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[78] C. Morimoto,et al. Dual‐label immunocytochemistry of the active multiple sclerosis lesion: Major histocompatibility complex and activation antigens , 1988, Annals of neurology.
[79] H. Lassmann,et al. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. , 1988, The American journal of pathology.
[80] G. Moore,et al. Balo's concentric sclerosis: New observations on lesion development , 1985, Annals of neurology.
[81] E. Cho,et al. Continual Breakdown and Regeneration of Myelin in Progressive Multiple Sclerosis Plaques a , 1984, Annals of the New York Academy of Sciences.
[82] M. Esiri,et al. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis , 1983, Journal of the Neurological Sciences.
[83] Y. P. Guo,et al. Concentric sclerosis. , 1983, Clinical and experimental neurology.
[84] L. Scheinberg,et al. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. , 1981, Laboratory investigation; a journal of technical methods and pathology.
[85] I. Allen,et al. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.
[86] K. Jellinger,et al. Einige morphologische Aspekte der Multiplen Sklerose , 1969 .
[87] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.
[88] R. Adams,et al. The morbid anatomy of the demyelinative diseases , 1952 .
[89] J. Baló. ENCEPHALITIS PERIAXIALIS CONCENTRICA , 1928 .
[90] A. Jakob,et al. Zur pathologie der multiplen sklerose mit besonderer berücksichtigung der akuten formen , 1913 .